Gold prices slip lower; consolidating after recent gains
David R. Epstein, a director at Tempus AI , Inc. (NASDAQ:TEM), recently sold 990 shares of the company’s Class A Common Stock. The artificial intelligence company, currently valued at $7.9 billion, has seen its stock perform strongly with a 42% gain year-to-date according to InvestingPro data. The transaction, executed on March 17, 2025, was completed at a price of $46.83 per share, totaling approximately $46,361. The stock currently trades at $48.03, slightly above the insider’s sale price. This sale was conducted under a Rule 10b5-1 trading plan, which Epstein adopted on August 27, 2024. Following the transaction, Epstein holds 26,284 shares directly. InvestingPro analysis shows the company maintains strong liquidity with a current ratio of 2.29, while operating with moderate debt levels. Additional insights and 7 more key ProTips are available with an InvestingPro subscription.
In other recent news, Tempus AI reported a significant 35.8% increase in revenue for the fourth quarter of 2024, reaching $700 million. However, the company’s earnings per share stood at -0.18, which may have influenced investor sentiment. Tempus AI has also revised its revenue guidance for 2025 to approximately $1.24 billion, incorporating contributions from its recent acquisition of Ambry Genetics. This acquisition is expected to enhance Tempus’s capabilities in AI-driven research platforms and expand its network in the healthcare sector. Stifel analysts maintained a Hold rating on Tempus AI, with a price target of $65, following the company’s earnings report. Meanwhile, JPMorgan downgraded Tempus AI from Overweight to Neutral but raised the price target to $55, citing the company’s recent earnings and valuation concerns. Additionally, Tempus AI has launched the Olivia AI personal health app, marking its entry into consumer health technology. These developments indicate Tempus AI’s ongoing strategic growth and expansion efforts in the healthcare technology industry.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.